Arena Pharmaceuticals (ARNA) used to be a publicly traded biopharmaceutical company focused on developing therapies targeting G protein-coupled receptors (GPCRs). Its stock was frequently discussed and tracked on Yahoo Finance, where investors monitored its performance, news releases, and analyst ratings. However, it’s important to note that Arena Pharmaceuticals was acquired by Pfizer in March 2022 and is no longer a publicly traded company. Therefore, you won’t find live, updated stock information for ARNA on Yahoo Finance anymore. Prior to its acquisition, Arena’s primary focus was on developing drugs for immuno-inflammatory diseases. Its most notable asset was etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator. This drug showed promise in treating diseases like ulcerative colitis and Crohn’s disease. Clinical trial results for etrasimod were frequently analyzed on platforms like Yahoo Finance as investors tried to gauge the drug’s potential and its impact on Arena’s stock price. Etrasimod’s development pipeline was a key factor driving investor interest in Arena. Positive clinical trial data often led to surges in the stock price, while setbacks or regulatory hurdles could cause declines. Analysts on Yahoo Finance and other financial news sites regularly provided commentary on etrasimod’s prospects, factoring in competition from other drugs in development and the overall market landscape. Beyond etrasimod, Arena had other early-stage programs in its pipeline. These assets were considered higher-risk, higher-reward opportunities. News and updates regarding these programs, while less impactful than etrasimod news, still contributed to the overall investor sentiment surrounding Arena. Before Pfizer’s acquisition, the ARNA stock price was subject to significant volatility. Biopharmaceutical companies, particularly those with a focus on novel therapies, often experience large swings in their stock prices based on clinical trial outcomes, regulatory approvals, and market expectations. Yahoo Finance provided a platform for investors to track this volatility, analyze price charts, and access financial data such as earnings reports and analyst estimates. The acquisition by Pfizer effectively ended Arena’s independent journey. Pfizer acquired Arena for approximately $6.7 billion, recognizing the potential of etrasimod and other assets in Arena’s portfolio. This acquisition integrated Arena’s programs into Pfizer’s larger pharmaceutical pipeline. Now that Arena is part of Pfizer, information about its former assets will be found under Pfizer’s (PFE) filings and press releases. Etrasimod, now under Pfizer’s ownership, continues to be developed and evaluated for its potential in treating various immuno-inflammatory conditions. Investors interested in the progress of etrasimod will now need to follow Pfizer’s announcements and research instead of specifically searching for ARNA on Yahoo Finance. The legacy of Arena Pharmaceuticals lives on through its contributions to the pharmaceutical landscape and the continued development of its key assets under Pfizer’s leadership.
1024×576 obesity drug flops arena pharma plans comeback work from www.statnews.com 
500×500 leerink starts arena pharma op biotuesdays from biotuesdays.com 
2560×1907 arena pharmaceuticals morgan design from morgandesign.com 
270×187 pharma stock pressure arena pharmaceuticals nasdaq arna from fxdailyreport.com 
409×122 investments portfolio arena capital from www.arenacapital.com 
560×316 arena pharma ceo targets brain diseases drug frontier from gubbagroup.com 
800×800 pharma market news finance funding expansion orsasaiwai from orsasaiwai.com 
1024×683 arena pharmaceuticals exterior smith consulting architects from sca-sd.com 
1500×832 arena pharmaceuticals smith consulting architects from sca-sd.com 
248×76 platform arena investors lp from www.arenaco.com 
1200×628 drug treatments arena pharmaceuticals pipeline from marketrealist.com 
1300×956 arena pharmaceuticals res stock photography images alamy from www.alamy.com 
800×800 arena pharmaceuticals logo png logo vector brand downloads svg eps from www.freelogovectors.net 
650×380 arena pharmaceuticals office from www.glassdoor.com 
456×190 arena pharmaceuticals trademark arena pharmaceuticals serial from www.trademarkia.com 
800×450 pfizer acquires arena pharmaceuticals citybiz from www.citybiz.co 
900×811 arena pharmaceuticals stock chart keski from keski.condesan-ecoandes.org 
450×300 companies arena pharmaceuticals from www.lifescienceleader.com 
1012×572 biotech arena stock rises study crohns disease investors from www.investors.com 
1920×1080 arena pharmaceuticals arna stock chart technical analysis from claytrader.com 
1200×794 arena pharmaceuticals stock today news from via.news 
1280×720 arena pharmaceuticals arna investor slideshow nyse from seekingalpha.com 
1000×667 high growth pharma stocks profitable insider monkey from www.insidermonkey.com 
1280×720 arena group aren investor slideshow nysearen from seekingalpha.com 
